Targeted cancer. These "smart weapons" hit cancer in novel ways.
Be prepared to recognize and manage a new collection of adverse reactions that may arise from these innovative approaches to cancer therapy.
Held-Warmkessel
Jeanne
J
Fox Chase Cancer Center in Philadelphia, PA, USA.
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D003967:Diarrhea / Q000139:chemically induced; D016503:Drug Delivery Systems / Q000009:adverse effects* / Q000379:methods* / Q000451:nursing; D003875:Drug Eruptions / Q000209:etiology; D004347:Drug Interactions; D016903:Drug Monitoring; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing; D024802:Nurse's Role; D009859:Oncology Nursing; D010304:Paronychia / Q000139:chemically induced; D010353:Patient Education as Topic; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D013280:Stomatitis / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases